These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18332126)

  • 1. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
    Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
    Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
    J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
    Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.
    Siegel PM; Shu W; Cardiff RD; Muller WJ; Massagué J
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8430-5. PubMed ID: 12808151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles.
    Schade B; Lam SH; Cernea D; Sanguin-Gendreau V; Cardiff RD; Jung BL; Hallett M; Muller WJ
    Cancer Res; 2007 Aug; 67(16):7579-88. PubMed ID: 17699761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ShcA signalling is essential for tumour progression in mouse models of human breast cancer.
    Ursini-Siegel J; Hardy WR; Zuo D; Lam SH; Sanguin-Gendreau V; Cardiff RD; Pawson T; Muller WJ
    EMBO J; 2008 Mar; 27(6):910-20. PubMed ID: 18273058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ; Schiemann WP
    Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner: increasing coherence in tyrosine phosphatase signaling.
    Kraut-Cohen J; Muller WJ; Elson A
    J Biol Chem; 2008 Feb; 283(8):4612-21. PubMed ID: 18093973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
    Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
    J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.
    Dankort DL; Wang Z; Blackmore V; Moran MF; Muller WJ
    Mol Cell Biol; 1997 Sep; 17(9):5410-25. PubMed ID: 9271418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.
    Muraoka RS; Koh Y; Roebuck LR; Sanders ME; Brantley-Sieders D; Gorska AE; Moses HL; Arteaga CL
    Mol Cell Biol; 2003 Dec; 23(23):8691-703. PubMed ID: 14612410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
    Khoury H; Dankort DL; Sadekova S; Naujokas MA; Muller WJ; Park M
    Oncogene; 2001 Feb; 20(7):788-99. PubMed ID: 11314013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
    Roovers K; Wagner S; Storbeck CJ; O'Reilly P; Lo V; Northey JJ; Chmielecki J; Muller WJ; Siegel PM; Sabourin LA
    Oncogene; 2009 Aug; 28(31):2839-48. PubMed ID: 19525980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Cbl is a suppressor of the neu oncogene.
    Levkowitz G; Oved S; Klapper LN; Harari D; Lavi S; Sela M; Yarden Y
    J Biol Chem; 2000 Nov; 275(45):35532-9. PubMed ID: 10940298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adaptor protein SHCA launches cancer invasion.
    Borah S; Bhowmick NA
    J Biol Chem; 2020 Jul; 295(31):10560-10561. PubMed ID: 32737145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
    Ahn R; Sabourin V; Ha JR; Cory S; Maric G; Im YK; Hardy WR; Zhao H; Park M; Hallett M; Siegel PM; Pawson T; Ursini-Siegel J
    Cancer Res; 2013 Jul; 73(14):4521-32. PubMed ID: 23695548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.
    Muller WJ; Arteaga CL; Muthuswamy SK; Siegel PM; Webster MA; Cardiff RD; Meise KS; Li F; Halter SA; Coffey RJ
    Mol Cell Biol; 1996 Oct; 16(10):5726-36. PubMed ID: 8816486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.